NMC Chairperson and NBEMS President Dr Abhijat Sheth recently pointed out that artificial intelligence will play an important ...
CYB003/CYB004 clinical catalysts into 2026, $248M cash runway, equity raises risk, valuation optionality. Click for this CYBN ...
Some clinicians have been treating sexual excess as an addiction without any scientific evidence. Now, a more ethical new era ...
Uganda it led an international team that delivered new eco-friendly headquarters in Kampala for two major United Nations ...
Adults with type 1 or type 2 diabetes who used a continuous glucose monitor experienced fewer emergency department and ...
Older adults who followed a structured health-related intervention experienced improved sleep-apnea related outcomes compared ...
Some people with SOD1-ALS experienced improvements in physical function and muscle strength after three years on Qalsody, an ...
Despite the definitive failure of Novo Nordisk’s semaglutide in Alzheimer’s, biotech executives, analysts and other industry ...
Figure][1] Michael Teitell, MD, PhD Dr. Michael Teitell is the director of the UCLA Health Jonsson Comprehensive Cancer ...
Issued on behalf of Avant Technologies Inc. VANCOUVER, BC, Jan. 2, 2026 /CNW/ — Equity Insider News Commentary – The gene therapy market is surging toward $36.55 billion by ...
In 2026, Medtronic plans to launch a new robot to compete with a legacy market leader. This new robot is reportedly cheaper ...
Swedish neurotech startup Flow Neuroscience has secured FDA approval for the first brain stimulation device for home use in ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback